Company intelligence / Profile preview

eMed

Miami, Florida, United States

Ownership: Private
Employees: ~1150
Development stage: Other

Overview

eMed operates a commercial telehealth and at-home diagnostics platform providing at-home blood testing, remote drug screening, and GLP-1/GIP-based chronic care and weight management programs, with reported average weight loss of about 21 lbs in 6 months in its GLP-1 program.[1][5][9]

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: DeviceNon-pharmacological therapySmall molecule
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on eMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on eMed.

Explore the full profile